Past Podcast Episodes

Living your best life while you're living with MS means learning how to manage and overcome the physical and psychological limitations that MS tries to impose. This week's guest, Dr. Kathleen Zackowski, Senior Director of Patient Management, Care, and Rehabilitation Research for the National MS Society, takes us on a deep dive into MS rehabilitation & symptom management.

We're also talking about the FDA approval of Gilenya for treating Pediatric MS, President Donald Trump's announced “blueprint to lower (prescription) drug prices,” and next week's International Progressive MS Alliance Scientific Congress on Rehabilitation & Symptom Management.

And…we're announcing some very special podcast episodes coming your way next week!!

We have a lot to talk about! Are you ready for RealTalk MS?

____________

The RealTalk MS Podcast & Alexa 1:35

FDA Approves Gilenya For Pediatric MS 3:13

President Trump Announces His Prescription Drug Strategy 4:30

MS Rehabilitation & Symptom Management 6:37

International Progressive MS Alliance Scientific Congress 9:35

Special Upcoming Podcast Episodes 10:32

Interview with Dr. Kathleen Zackowski 11:21

___________

LINKS
If your podcast app doesn't show these links, you'll find them in the show notes at www.RealTalkMS.com

The RealTalk MS Podcast Alexa Skill

FDA Approves Gilenya for Pediatric MS

The International Progressive MS Alliance

Give RealTalk MS a Rating & Review

___________

Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.

RealTalk MS Episode 32
Guest: Dr. Kathleen Zackowski
Hosted By: Jon Strum

Tags: MS, multipleSclerosis, Alexa, Gilenya, MSRehabilitation, Rehabilitation, AllianceCongress2018, RealTalkMS

In 2004, the average wholesale price of available MS disease-modifying therapies was $16,000. In 2013, the average price was $61,000; last year, the average price was more than $83,000. That's why I was anxious to bring on my guest this week, David Mitchell, the founder and president of Patients for Affordable Drugs.

We're also talking about the RealTalk MS Podcast Alexa Skill! If you already own an Amazon Echo, Dot, or any Alexa-enabled device, you can access all sorts of convenient features for listening to RealTalk MS! (And if you don't yet have an Alexa-enabled device, this might be one more reason to get one!)

A new study concludes that Autologous Haematopoietic Stem Cell Therapy is safe and effective in treating ‘aggressive' MS. Another pilot study demonstrates that aspirin can help prevent the onset of overheating and exhaustion following exercise. And your future appointments with your neurologist may take place from the comfort of your own home.

We have a lot to talk about! Are you ready for RealTalk MS?

____________

Our Alexa Announcement :27

Study Shows Autologous Hematopoietic Stem Cell Therapy Safe & Effective In Treating “Aggressive” MS 4:40

Overheating When You Exercise? Study Recommends Taking 2 Aspirin 8:06

How About Having Your Next Appointment With Your Neurologist At Home? 10:15

Interview with David Mitchell 13:00

___________

LINKS
If your podcast app doesn't show these links, you'll find them in the show notes at www.RealTalkMS.com

The RealTalk MS Podcast Alexa Skill

STUDY: Autologous Haematopoietic Stem Cell Transplantation in Treatment Naive Patients with ‘Aggressive' Multiple Sclerosis

STUDY: A Randomized Controlled Pilot Trial of Aspirin to Improve Exercise Performance in Persons with Multiple Sclerosis